New tracer could sharpen lung cancer PET scans

NCT ID NCT07487883

Recruiting now Diagnosis Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new radioactive tracer called 68Ga-TOI-1 for PET scans in people with lung cancer or suspicious lung nodules. The tracer targets a protein (CDH3) found only on cancer cells, which may help doctors see tumors more clearly than current scans. About 80 participants will receive the tracer and undergo PET/CT imaging to see how well it detects and stages the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 68Ga-TOI-1 (a radioactive tracer for PET scans)
What this could lead to: If successful, this could provide a more accurate way to detect and stage lung cancer, helping doctors choose the best treatment.
What could go wrong: This is an early-stage study with only 80 participants. The new tracer may not prove more effective than existing scans, and results may not apply to all lung cancer types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Multiple Pulmonary Nodules neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT NEOPLASM NON-SMALL CELL LUNG CANCER PET/CT PULMONARY NODULES

Contacts and locations

Locations

Peking University People's Hospital
RECRUITING

Beijing, Beijing Municipality, 100044, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.